title: Liposomal nanomedicine for breast cancer therapy.
abstract: Liposomes are well-established nanocarriers for improving the therapeutic index of anticancer agents. A remarkable understanding in the pathophysiology of breast cancer progression has emerged with information on the involved specific biomolecules, which may serve as molecular targets for its therapy. Hormonal and nonhormonal receptors can both be exploited for targeting to breast cancer cells. Targeted delivery of cytotoxic drugs using liposomes is a novel approach for breast cancer therapy. In the present article, we summarize molecular targets present on the breast cancer cells. Recent developments in liposome-based delivery of bioactives for selective treatments of breast cancer are discussed. In addition, utilization of bioenvironmental conditions of tumor for liposome-based targeted delivery is also summed up.
authors.affiliation: Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour Vishwavidyalaya, Sagar, M.P., India.
authors.forename: Shivani Rai
authors.initials: SR
authors.lastname: Paliwal
authors.forename: Rishi
authors.initials: R
authors.lastname: Paliwal
authors.forename: Govind P
authors.initials: GP
authors.lastname: Agrawal
authors.forename: Suresh P
authors.initials: SP
authors.lastname: Vyas
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry* / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage* / Q000737:chemistry*; D050997:Nanomedicine / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents; D008081:Liposomes